What is BSF Enterprise?
Founded in 2018 by Geoff Baker, BSF Enterprise operates at the intersection of biotechnology and sustainable manufacturing. The company leverages its core technology platform to produce scaffold-free structured tissues, effectively bypassing the traditional limitations of cell-based production. By utilizing its 3D Bio-Tissues division, the firm provides high-performance media supplements and tissue structures that serve as the foundation for its diverse product lines. These include Cultivated Meat Technologies, which focuses on cost-competitive, high-protein food alternatives, and Lab-Grown Leather, which produces 3DBT Skin. This material replicates the structural integrity of conventional leather without the need for synthetic scaffolds, offering a high-quality, sustainable alternative for the fashion and automotive industries. The company's ability to scale these solutions across multiple species and applications positions it as a significant player in the global bio-manufacturing landscape.
How much funding has BSF Enterprise raised?
BSF Enterprise has raised a total of $19.8M across 1 funding round:
Private Equity
$19.8M
Private Equity (2025): $19.8M with participation from Blackstone
Key Investors in BSF Enterprise
Blackstone
Blackstone is a global investment firm that focuses on building and managing diversified asset portfolios across private equity, real estate, credit and strategic alternatives.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for BSF Enterprise?
With this major enterprise-level funding, BSF Enterprise is expected to transition from pilot-scale development to full-scale commercialization. The strategic allocation of capital will likely focus on expanding production capacity for its cultivated meat and leather divisions, while simultaneously refining its proprietary media supplement formulations to drive down unit costs. As the company matures, it will likely seek to deepen its partnerships within the medtech and luxury goods sectors, leveraging its unique scaffold-free technology to capture market share from traditional, resource-intensive industries. The focus remains on achieving price parity with conventional products, a critical milestone for widespread adoption in the global market.
See full BSF Enterprise company page
